Artiva Biotherapeutics is advancing NK cell therapy and CAR-NK therapy for cancer, including blood cancers and solid tumors.

Education

Biotechnology

Artiva Biotherapeutics

Fred Aslan

Scott C.

Sungyong Won

Mark Bravo

Luis Solchaga

Heather Raymon

Thorsten Graef

Eugene Helsel

Christopher Horan

Jennifer Bush

Peter Flynn

The Research and Pharmaceutical Sciences team at Artiva Biotherapeutics focuses on advancing natural killer (NK) cell therapy and CAR-NK therapy for treating blood cancers and solid tumors. They conduct cutting-edge research and translational science in pharmacology, aiming to innovate and enhance therapeutic strategies for effective cancer treatment.

Research and Pharmaceutical Sciences

Directors and Associate Directors

Leadership Team

Advisory Team

Research and Pharmaceutical Sciences

About

Team members

Other teams at Artiva Biotherapeutics

Directors and Associate Directors

Leadership Team

Advisory Team